Value Chain; Strategy Map; Role in Corporate Alliances A recent report of the consultingfirm McKinsey & Company indicates that about one-half of all corporate alliances fail. These alliances are partnerships in which two corporations jointly participate in one or more of the activities inthe industry value chain. A good example, provided by Robert S. Kaplan and David P. Norton (creators of the balanced scorecard and strategy map), is the alliance between the European pharmaceutical company, Solvay, and U.S.-based Quintiles, a company that specializes in the conduct of clinicaltrials for testing potential new drugs. Solvay’s strategy is to employ its research-driven organizationto develop and market new drugs. One of the steps in Solvay’s value chain is to complete the testingrequired by the U.S. Food and Drug Administration. Rather than divert its operations from research,Solvay has partnered with Quintiles. Realizing that they both benefit from the success and growth ofSolvay’s products, the two companies have developed a joint strategy map and identified the criticaldrivers for the joint success of the alliance.Required Considering the Solvay–Quintiles collaboration, we know that about 50% of such alliances fail.Explain briefly how you think the strategy map and value-chain analysis can help this alliance to succeed.
Value Chain; Strategy Map; Role in Corporate Alliances A recent report of the consulting
firm McKinsey & Company indicates that about one-half of all corporate alliances fail. These alliances are partnerships in which two corporations jointly participate in one or more of the activities in
the industry value chain. A good example, provided by Robert S. Kaplan and David P. Norton (creators of the balanced scorecard and strategy map), is the alliance between the European pharmaceutical company, Solvay, and U.S.-based Quintiles, a company that specializes in the conduct of clinical
trials for testing potential new drugs. Solvay’s strategy is to employ its research-driven organization
to develop and market new drugs. One of the steps in Solvay’s value chain is to complete the testing
required by the U.S. Food and Drug Administration. Rather than divert its operations from research,
Solvay has partnered with Quintiles. Realizing that they both benefit from the success and growth of
Solvay’s products, the two companies have developed a joint strategy map and identified the critical
drivers for the joint success of the alliance.
Required Considering the Solvay–Quintiles collaboration, we know that about 50% of such alliances fail.
Explain briefly how you think the strategy map and value-chain analysis can help this alliance to succeed.
Trending now
This is a popular solution!
Step by step
Solved in 3 steps
